Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study

An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme

NCT06734078 ·Status: ACTIVE_NOT_RECRUITING

Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma

NCT03797170 ·Status: UNKNOWN

Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context

NCT06781450 ·Status: RECRUITING

Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach

NCT07147751 ·Status: NOT_YET_RECRUITING

Study of Prognostic Factors in Adult Lymphoblastic Lymphoma

NCT03571997 ·Status: UNKNOWN

An Italian Experience on Grade 3b Follicular Lymphoma

NCT02927717 ·Status: UNKNOWN

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

NCT05700149 ·Status: RECRUITING

Molecular Characterization and Outcomes of Aggressive B-Cell Lymphomas.

NCT07181785 ·Status: COMPLETED

Italian Multicenter Retrospective Observational Study on Transformed Lymphomas

NCT02927756 ·Status: UNKNOWN

Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)

NCT04824950 ·Status: RECRUITING ·Phase: NA

Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)

NCT05253118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

NCT06781437 ·Status: RECRUITING

Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma

NCT05590221 ·Status: RECRUITING ·Phase: PHASE2

A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma

NCT06554561 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Italian Study of Patients With Lymphoma

NCT06814925 ·Status: RECRUITING

Fase II Study With BRB for Non-Hodgkin Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia's

NCT02371148 ·Status: COMPLETED ·Phase: PHASE2

Study of Lymphoma in Asia

NCT01584141 ·Status: COMPLETED

A Phase I/II Study of Diffuse Large B-cell Lymphoma

NCT04856137 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy

NCT06782854 ·Status: COMPLETED

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients

NCT00949741 ·Status: COMPLETED

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

NCT06806488 ·Status: RECRUITING

Bendamustine/Lenalidomide/Rituximab: Combination as a Second-Line Therapy for 1st Relapsed-Refractory MCL

NCT01737177 ·Status: COMPLETED ·Phase: PHASE2

Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma

NCT00556127 ·Status: COMPLETED ·Phase: PHASE2

Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma

NCT00992134 ·Status: COMPLETED ·Phase: PHASE2

Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.

NCT05347511 ·Status: UNKNOWN